Pittsburgh Man Inoculated with Moderna COVID-19 Vaccine Dies of Rare Blood Clot

While the researchers felt that reaction to the Moderna jab was the likely cause of the patient’s thrombosis, they still felt that the benefits of receiving the vaccine outweighed the potential hazards.
While the researchers felt that reaction to the Moderna jab was the likely cause of the patient’s thrombosis, they still felt that the benefits of receiving the vaccine outweighed the potential hazards. File photo: Giovanni Cancemi, Shutterstock.com, licensed.

PENNSYLVANIA – According to reports, a Pittsburgh man who had received his second dose of the Moderna COVID-19 vaccine has passed away of a rare, serious blood clot disorder that had previously only been associated with the Johnson & Johnson and AstraZeneca vaccines.

The patient, aged 65 – who was suffering from chronic hypertension and hyperlipidemia – reportedly began showing the symptoms associated with the blood clot disorder 10 days after receiving his second jab, including bilateral lower-extremity discomfort, intermittent headaches, and shortness of breath.

According to the Annals of Internal Medicine by researchers from the Allegheny Health Network, which documented the case, it is the first known instance of thrombosis with thrombocytopenia associated with the Moderna vaccine.


FREE DIGITAL SUBSCRIPTION: GET ONLY 'FEATURED' STORIES BY EMAIL

Big Tech is using a content filtering system for online censorship. Watch our short video about NewsGuard to learn how they control the narrative for the Lamestream Media and help keep you in the dark. NewsGuard works with Big-Tech to make it harder for you to find certain content they feel is 'missing context' or stories their editors deem "not in your best interest" - regardless of whether they are true and/or factually accurate. They also work with payment processors and ad-networks to cut off revenue streams to publications they rate poorly by their same bias standards. This should be criminal in America. You can bypass this third-world nonsense by signing up for featured stories by email and get the good stuff delivered right to your inbox.
 

The patient checked himself into a hospital, and upon examination, doctors discovered acute deep venous thromboses in both legs, acute pulmonary emboli with right ventricular strain, and severe thrombocytopenia, or low blood platelet count. Various treatments proved ineffective, reports say, and as the thrombosis worsened the patient continued to deteriorate and eventually developed a skin-based staph infection. The patent eventually succumbed and died, according to officials, after “compassionate extubation,” which is the removal of a tube previously inserted into a patient’s body, especially that of an artificial ventilation tube from the trachea.

Researchers from the Allegheny Health Network noted in their report that the patient “developed thrombocytopenia and thrombosis within 5 to 10 days after vaccine administration. The distribution of thrombosis, especially the cerebral venous sinus thrombosis, was characteristic of [Vaccine-induced Thrombotic Thrombocytopenia] or [Thrombosis with Thrombocytopenia Syndrome]. Most of his clotting and other relevant work-up were consistent with the syndrome.”

However, while the researchers felt that reaction to the Moderna jab was the likely cause of the patient’s thrombosis, they still felt that the benefits of receiving the vaccine outweighed the potential hazards.

“In summary, we believe it is important to note that millions of people have received COVID-19 vaccines that use [Moderna] technology,” the researchers said. “This is the only report to date of possible VITT or TTS in those recipients and as such a rare event, even if confirmed by additional reports, should not prevent persons from receiving the benefits of these vaccines.”


Comment via Facebook

Corrections: If you are aware of an inaccuracy or would like to report a correction, we would like to know about it. Please consider sending an email to corrections@publishedreporter.com and cite any sources if available. Thank you. (Policy)